Effect of Persian medicine product on the recovery and relapse of bacterial vaginosis

Phase 3

Recruiting

Conditions: Bacterial vaginosis.
N76.0
Acute vagi

Registration Number: IRCT20200926048840N1

Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: Female

Target Recruitment: 60

Inclusion Criteria

Married women
18 -50 years old
Positive at least 3 out of 4 Amsel criteria

Exclusion Criteria

Pregnancy
Lactation
Menopause
Vaginal bleeding
Use of antibiotics in the last 4 weeks
Known chronic diseases
Using oral contraceptives to prevent pregnancy
Smoking and Consuming alcohol
Using Coumarin anticoagulants
Multiple sexual partners
Diarrhea

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Cure (Elimination of all Amsel criteria or remaining only one criterion and according to the agent scoring system, a score of 1 to 3 or 4 to 6 without key cells). Timepoint: 10 days after the start of treatment and 30 days after the end of treatment. Method of measurement: Amsel and Najnat criteria.

Secondary Outcome Measures

Name	Time	Method
Vaginal discharge. Timepoint: 10 days after the start of treatment and 30 days after the end of treatment. Method of measurement: observation.;Vaginal acidity. Timepoint: 10 days after the start of treatment and 30 days after the end of treatment. Method of measurement: Ph strip.;Whiff test. Timepoint: 10 days after the start of treatment and 30 days after the end of treatment. Method of measurement: Koh 10% solution.;Clue cells. Timepoint: 10 days after the start of treatment and 30 days after the end of treatment. Method of measurement: Evaluation of clue cells in the wet lam.;Nagnet score. Timepoint: 10 days after the start of treatment and 30 days after the end of treatment. Method of measurement: Evaluation of stained slide.